Drug discounts at mercy of courts | FDA recall on Olympus devices after 113 injuries | Patient comms AI earns $65M in PE funds

HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time. 

The nylon loop on some devices can fail to release while removing polyps. Because of the severe risk to patient health, the FDA has designated this recall a Class I.

Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.

Will there or won’t there be a federal moratorium on state-level regulation of AI? That’s only one question healthcare stakeholders are asking as 2025’s time begins running out.

Authorities allege the pharmacy chain gave patients more insulin than prescribed and then billed Medicare and Medicaid for the full amounts. This allegedly occurred for more than a decade. 

A psychiatric patient suffering from hallucinations injured employees at University of Iowa Health Care during a physical altercation. Clinicians restrained and sedated him successfully, but the cocktail of drugs allegedly caused his heart to stop, leading to a permanent brain injury. The case has been settled out of court.

The insurer claims personal injury attorneys referred patients to the network, where they allegedly received dubious treatments and undergo excessive testing to inflate medical claims. Allstate is seeking up to $5.2 million in restitution.

With the U.S. Senate passing a funding agreement to reopen the federal government, the House of Representatives will now have a chance to make changes—though there’s little chance this particular amendment will succeed.

SCAI and CRT have announced a new partnership focused on education, advocacy and research.

Between 20% to 24% of all breast cancers diagnosed during a decade-long period were found in women between the ages of 18 to 49, according to research presented at RSNA 2025.